BioRegenx, Inc.
BRGX
$0.0129
$0.001917.27%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -142.09% | -911.12% | -- | -- | -- |
| Total Depreciation and Amortization | -- | 89,091.67% | -- | -- | -- |
| Total Amortization of Deferred Charges | 566.10% | 420.34% | -- | -- | -- |
| Total Other Non-Cash Items | 25.55% | 147,511.11% | -- | -- | -- |
| Change in Net Operating Assets | -2.22% | -10.68% | -- | -- | -- |
| Cash from Operations | -21.66% | -56.26% | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,165.45% | -1,165.45% | -- | -- | -- |
| Total Debt Issued | 132.12% | 131.60% | -- | -- | -- |
| Total Debt Repaid | 153.27% | 154.25% | -- | -- | -- |
| Issuance of Common Stock | -- | -91.59% | -- | -- | -- |
| Repurchase of Common Stock | -1,744.12% | -1,744.12% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 78.81% | 87.36% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -105.58% | -92.39% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 359.60% | 16.58% | -- | -- | -- |
